COVID-19 FAQ: Can we block the destructive ‘cytokine storm’ that kills critically ill patients?
Recent research suggests that scientists have found a way to limit the devastating immune overreaction in COVID-19 that can result in death....
Recent research suggests that scientists have found a way to limit the devastating immune overreaction in COVID-19 that can result in death....
Convalescent plasma (CP) therapy to treat hospitalised COVID-19 patients has received emergency use authorisation (EUA) from the FDA in the United States. This kind of therapy is a classic prevention and treatment strategy against...
For a long time during the COVID-19 pandemic, the novel coronavirus was associated primarily with lung damage. However, emerging research suggests an array of other conditions survivors of a severe form COVID-19 need to cope with....
Although about 80 per cent of people with symptoms of Covid-19 experience only a mild form of the disease, those patients who have spent time in intensive care units (ICU) often have long months of rehabilitation ahead of them....